137 related articles for article (PubMed ID: 3258427)
1. Rotation following intranigral injections of a selective D1 or a selective D2 dopamine receptor agonist in rats.
Asin KE; Montana WE
Pharmacol Biochem Behav; 1988 Jan; 29(1):89-92. PubMed ID: 3258427
[TBL] [Abstract][Full Text] [Related]
2. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
3. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
Fletcher GH; Starr MS
Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
[TBL] [Abstract][Full Text] [Related]
4. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
5. Rotation in response to selective dopamine receptor agonists in rats with electrolytic substantia nigra lesions.
Asin KE; Bednarz L; Montana W
Life Sci; 1990; 46(25):1817-23. PubMed ID: 1972973
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
Robertson GS; Robertson HA
Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
[TBL] [Abstract][Full Text] [Related]
7. Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats.
Arnt J; Bøgesø KP; Hyttel J; Meier E
Pharmacol Toxicol; 1988 Mar; 62(3):121-30. PubMed ID: 3259694
[TBL] [Abstract][Full Text] [Related]
8. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Sonsalla PK; Manzino L; Heikkila RE
J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
[TBL] [Abstract][Full Text] [Related]
9. Production of climbing behaviour in mice requires both D1 and D2 receptor activation.
Moore NA; Axton MS
Psychopharmacology (Berl); 1988; 94(2):263-6. PubMed ID: 2895485
[TBL] [Abstract][Full Text] [Related]
10. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
11. Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions.
Trugman JM; Wooten GF
J Neurosci; 1987 Sep; 7(9):2927-35. PubMed ID: 3114439
[TBL] [Abstract][Full Text] [Related]
12. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
13. Behavioral interactions between muscimol and compounds selective for the D1 and D2 dopamine receptor subtypes.
Asin KE; Bednarz LM
Neurosci Lett; 1990 Jun; 113(3):286-91. PubMed ID: 2143274
[TBL] [Abstract][Full Text] [Related]
14. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
15. Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.
Sañudo-Peña MC; Patrick SL; Patrick RL; Walker JM
Neurosci Lett; 1996 Mar; 206(1):21-4. PubMed ID: 8848272
[TBL] [Abstract][Full Text] [Related]
16. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
Puglisi-Allegra S; Cabib S
Pharmacol Biochem Behav; 1988 Jul; 30(3):765-8. PubMed ID: 2974996
[TBL] [Abstract][Full Text] [Related]
17. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
Ross SB; Jackson DM; Wallis EM; Edwards SR
Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):512-8. PubMed ID: 3261844
[TBL] [Abstract][Full Text] [Related]
18. D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
Koller WC; Herbster G
Clin Neuropharmacol; 1988 Jun; 11(3):221-31. PubMed ID: 3261198
[TBL] [Abstract][Full Text] [Related]
19. Intranigral injections of SCH 23390 inhibit SKF 82958-induced rotational behavior.
Yurek DM; Hipkens SB
Brain Res; 1994 Mar; 639(2):329-32. PubMed ID: 7911393
[TBL] [Abstract][Full Text] [Related]
20. Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.
Dall'Olio R; Gandolfi O; Vaccheri A; Roncada P; Montanaro N
Psychopharmacology (Berl); 1988; 95(3):381-5. PubMed ID: 2901128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
